Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT05158023 · COMPLETED
Trial details
- NCT number
- NCT05158023
- Sponsor
- ASLAN Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-16
- Primary completion
- 2023-06-13
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.